APO Research
Talk to an analyst

APO RESEARCH · REPORT

Aurora Kinase A

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Aurora Kinase A Industry Growth and Trends Forecast to 2032

19 December 2025105 pages

Choose your research edition.

Industry ResearchAurora Kinase A Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Aurora Kinase A Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Aurora Kinase A Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Aurora Kinase A Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Aurora Kinase A Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Aurora Kinase A market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Aurora Kinase A is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Aurora Kinase A is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Aurora Kinase A is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Aurora Kinase A include Sanofi, Merck & Co., Inc., Amgen Inc., AbbVie Inc., Vichem Chemie Research Ltd., Vertex Pharmaceuticals Incorporated, Taiho Pharmaceutical Co., Ltd., Sigma-Tau S.p.A. and Sareum Holdings Plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Aurora Kinase A market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Aurora Kinase A market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Aurora Kinase A market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Aurora Kinase A.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Aurora Kinase A market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Aurora Kinase A Market by Company

Sanofi

Merck & Co., Inc.

Amgen Inc.

AbbVie Inc.

Vichem Chemie Research Ltd.

Vertex Pharmaceuticals Incorporated

Taiho Pharmaceutical Co., Ltd.

Sigma-Tau S.p.A.

Sareum Holdings Plc

Millennium Pharmaceuticals, Inc.

CASI Pharmaceuticals Inc.

Astex Pharmaceuticals, Inc.

Aurora Kinase A Segment by Type

AMG-900

Ilorasertib

ENMD-2076

Danusertib

Others

Aurora Kinase A Segment by Application

Brain Tumor

Ovarian Cancer

Anaplastic Large Cell Lymphoma

Others

Aurora Kinase A Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aurora Kinase A market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aurora Kinase A and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aurora Kinase A.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Aurora Kinase A manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Aurora Kinase A in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of AMG-900 Table 2. Major Company of Ilorasertib Table 3. Major Company of ENMD-2076 Table 4. Major Company of Danusertib Table 5. Major Company of Others Table 6. Global Aurora Kinase A Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Aurora Kinase A Sales by Type (2021-2026) & (K Units) Table 8. Global Aurora Kinase A Sales Market Share in Volume by Type (2021-2026) Table 9. Global Aurora Kinase A Sales by Type (2021-2026) & (US$ Million) Table 10. Global Aurora Kinase A Sales Market Share in Value by Type (2021-2026) Table 11. Global Aurora Kinase A Price by Type (2021-2026) & (US$/Unit) Table 12. Global Aurora Kinase A Sales by Type (2027-2032) & (K Units) Table 13. Global Aurora Kinase A Sales Market Share in Volume by Type (2027-2032) Table 14. Global Aurora Kinase A Sales by Type (2027-2032) & (US$ Million) Table 15. Global Aurora Kinase A Sales Market Share in Value by Type (2027-2032) Table 16. Global Aurora Kinase A Price by Type (2027-2032) & (US$/Unit) Table 17. North America Aurora Kinase A Sales by Type (2021-2026) & (K Units) Table 18. North America Aurora Kinase A Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Aurora Kinase A Sales by Type (2021-2026) & (K Units) Table 20. Europe Aurora Kinase A Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Aurora Kinase A Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Aurora Kinase A Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Aurora Kinase A Sales by Type (2021-2026) & (K Units) Table 24. Latin America Aurora Kinase A Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Aurora Kinase A Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Aurora Kinase A Sales by Type (2021-2026) & (US$ Million) Table 27. Aurora Kinase A Industry Trends Table 28. Aurora Kinase A Industry Drivers Table 29. Aurora Kinase A Industry Opportunities and Challenges Table 30. Aurora Kinase A Industry Restraints Table 31. Global Aurora Kinase A Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Aurora Kinase A Revenue Market Share by Company (2021-2026) Table 33. Global Aurora Kinase A Sales by Company (2021-2026) & (K Units) Table 34. Global Aurora Kinase A Sales Share by Company (2021-2026) Table 35. Global Aurora Kinase A Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Aurora Kinase A Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Aurora Kinase A Major Company Production Sites and Headquarters Table 38. Global Aurora Kinase A Company, Product Type & Application Table 39. Global Aurora Kinase A Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Aurora Kinase A by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Aurora Kinase A Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Aurora Kinase A Sales by Region (2021-2026) & (K Units) Table 44. Global Aurora Kinase A Sales Market Share in Volume by Region (2021-2026) Table 45. Global Aurora Kinase A Sales by Region (2021-2026) & (US$ Million) Table 46. Global Aurora Kinase A Sales Market Share in Value by Region (2021-2026) Table 47. Global Aurora Kinase A Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Aurora Kinase A Sales by Region (2027-2032) & (K Units) Table 49. Global Aurora Kinase A Sales Market Share in Volume by Region (2027-2032) Table 50. Global Aurora Kinase A Sales by Region (2027-2032) & (US$ Million) Table 51. Global Aurora Kinase A Sales Market Share in Value by Region (2027-2032) Table 52. Global Aurora Kinase A Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Aurora Kinase A Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Aurora Kinase A Sales by Application (2021-2026) & (K Units) Table 55. Global Aurora Kinase A Sales Market Share in Volume by Application (2021-2026) Table 56. Global Aurora Kinase A Sales by Application (2021-2026) & (US$ Million) Table 57. Global Aurora Kinase A Sales Market Share in Value by Application (2021-2026) Table 58. Global Aurora Kinase A Price by Application (2021-2026) & (US$/Unit) Table 59. Global Aurora Kinase A Sales by Application (2027-2032) & (K Units) Table 60. Global Aurora Kinase A Sales Market Share in Volume by Application (2027-2032) Table 61. Global Aurora Kinase A Sales by Application (2027-2032) & (US$ Million) Table 62. Global Aurora Kinase A Sales Market Share in Value by Application (2027-2032) Table 63. Global Aurora Kinase A Price by Application (2027-2032) & (US$/Unit) Table 64. North America Aurora Kinase A Sales by Application (2021-2026) & (K Units) Table 65. North America Aurora Kinase A Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Aurora Kinase A Sales by Application (2021-2026) & (K Units) Table 67. Europe Aurora Kinase A Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Aurora Kinase A Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Aurora Kinase A Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Aurora Kinase A Sales by Application (2021-2026) & (K Units) Table 71. Latin America Aurora Kinase A Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Aurora Kinase A Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Aurora Kinase A Sales by Application (2021-2026) & (US$ Million) Table 74. Sanofi Company Information Table 75. Sanofi Business Overview Table 76. Sanofi Aurora Kinase A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Sanofi Aurora Kinase A Product Portfolio Table 78. Sanofi Recent Development Table 79. Merck & Co., Inc. Company Information Table 80. Merck & Co., Inc. Business Overview Table 81. Merck & Co., Inc. Aurora Kinase A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Merck & Co., Inc. Aurora Kinase A Product Portfolio Table 83. Merck & Co., Inc. Recent Development Table 84. Amgen Inc. Company Information Table 85. Amgen Inc. Business Overview Table 86. Amgen Inc. Aurora Kinase A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Amgen Inc. Aurora Kinase A Product Portfolio Table 88. Amgen Inc. Recent Development Table 89. AbbVie Inc. Company Information Table 90. AbbVie Inc. Business Overview Table 91. AbbVie Inc. Aurora Kinase A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. AbbVie Inc. Aurora Kinase A Product Portfolio Table 93. AbbVie Inc. Recent Development Table 94. Vichem Chemie Research Ltd. Company Information Table 95. Vichem Chemie Research Ltd. Business Overview Table 96. Vichem Chemie Research Ltd. Aurora Kinase A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Vichem Chemie Research Ltd. Aurora Kinase A Product Portfolio Table 98. Vichem Chemie Research Ltd. Recent Development Table 99. Vertex Pharmaceuticals Incorporated Company Information Table 100. Vertex Pharmaceuticals Incorporated Business Overview Table 101. Vertex Pharmaceuticals Incorporated Aurora Kinase A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Vertex Pharmaceuticals Incorporated Aurora Kinase A Product Portfolio Table 103. Vertex Pharmaceuticals Incorporated Recent Development Table 104. Taiho Pharmaceutical Co., Ltd. Company Information Table 105. Taiho Pharmaceutical Co., Ltd. Business Overview Table 106. Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Product Portfolio Table 108. Taiho Pharmaceutical Co., Ltd. Recent Development Table 109. Sigma-Tau S.p.A. Company Information Table 110. Sigma-Tau S.p.A. Business Overview Table 111. Sigma-Tau S.p.A. Aurora Kinase A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Sigma-Tau S.p.A. Aurora Kinase A Product Portfolio Table 113. Sigma-Tau S.p.A. Recent Development Table 114. Sareum Holdings Plc Company Information Table 115. Sareum Holdings Plc Business Overview Table 116. Sareum Holdings Plc Aurora Kinase A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Sareum Holdings Plc Aurora Kinase A Product Portfolio Table 118. Sareum Holdings Plc Recent Development Table 119. Millennium Pharmaceuticals, Inc. Company Information Table 120. Millennium Pharmaceuticals, Inc. Business Overview Table 121. Millennium Pharmaceuticals, Inc. Aurora Kinase A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Millennium Pharmaceuticals, Inc. Aurora Kinase A Product Portfolio Table 123. Millennium Pharmaceuticals, Inc. Recent Development Table 124. CASI Pharmaceuticals Inc. Company Information Table 125. CASI Pharmaceuticals Inc. Business Overview Table 126. CASI Pharmaceuticals Inc. Aurora Kinase A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. CASI Pharmaceuticals Inc. Aurora Kinase A Product Portfolio Table 128. CASI Pharmaceuticals Inc. Recent Development Table 129. Astex Pharmaceuticals, Inc. Company Information Table 130. Astex Pharmaceuticals, Inc. Business Overview Table 131. Astex Pharmaceuticals, Inc. Aurora Kinase A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Astex Pharmaceuticals, Inc. Aurora Kinase A Product Portfolio Table 133. Astex Pharmaceuticals, Inc. Recent Development Table 134. North America Aurora Kinase A Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 135. North America Aurora Kinase A Sales by Country (2021-2026) & (K Units) Table 136. North America Aurora Kinase A Sales Market Share by Country (2021-2026) Table 137. North America Aurora Kinase A Sales Forecast by Country (2027-2032) & (K Units) Table 138. North America Aurora Kinase A Sales Market Share Forecast by Country (2027-2032) Table 139. North America Aurora Kinase A Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. North America Aurora Kinase A Market Size by Country (2021-2026) & (US$ Million) Table 141. North America Aurora Kinase A Market Share by Country (2021-2026) Table 142. North America Aurora Kinase A Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. North America Aurora Kinase A Market Share Forecast by Country (2027-2032) Table 144. Europe Aurora Kinase A Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 145. Europe Aurora Kinase A Sales by Country (2021-2026) & (K Units) Table 146. Europe Aurora Kinase A Sales Market Share by Country (2021-2026) Table 147. Europe Aurora Kinase A Sales Forecast by Country (2027-2032) & (K Units) Table 148. Europe Aurora Kinase A Sales Market Share Forecast by Country (2027-2032) Table 149. Europe Aurora Kinase A Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Europe Aurora Kinase A Market Size by Country (2021-2026) & (US$ Million) Table 151. Europe Aurora Kinase A Market Share by Country (2021-2026) Table 152. Europe Aurora Kinase A Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Europe Aurora Kinase A Market Share Forecast by Country (2027-2032) Table 154. Asia-Pacific Aurora Kinase A Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 155. Asia-Pacific Aurora Kinase A Sales by Country (2021-2026) & (K Units) Table 156. Asia-Pacific Aurora Kinase A Sales Market Share by Country (2021-2026) Table 157. Asia-Pacific Aurora Kinase A Sales Forecast by Country (2027-2032) & (K Units) Table 158. Asia-Pacific Aurora Kinase A Sales Market Share Forecast by Country (2027-2032) Table 159. Asia-Pacific Aurora Kinase A Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Asia-Pacific Aurora Kinase A Market Size by Country (2021-2026) & (US$ Million) Table 161. Asia-Pacific Aurora Kinase A Market Share by Country (2021-2026) Table 162. Asia-Pacific Aurora Kinase A Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Asia-Pacific Aurora Kinase A Market Share Forecast by Country (2027-2032) Table 164. Latin America Aurora Kinase A Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 165. Latin America Aurora Kinase A Sales by Country (2021-2026) & (K Units) Table 166. Latin America Aurora Kinase A Sales Market Share by Country (2021-2026) Table 167. Latin America Aurora Kinase A Sales Forecast by Country (2027-2032) & (K Units) Table 168. Latin America Aurora Kinase A Sales Market Share Forecast by Country (2027-2032) Table 169. Latin America Aurora Kinase A Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Latin America Aurora Kinase A Market Size by Country (2021-2026) & (US$ Million) Table 171. Latin America Aurora Kinase A Market Share by Country (2021-2026) Table 172. Latin America Aurora Kinase A Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Latin America Aurora Kinase A Market Share Forecast by Country (2027-2032) Table 174. Middle East and Africa Aurora Kinase A Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 175. Middle East and Africa Aurora Kinase A Sales by Country (2021-2026) & (K Units) Table 176. Middle East and Africa Aurora Kinase A Sales Market Share by Country (2021-2026) Table 177. Middle East and Africa Aurora Kinase A Sales Forecast by Country (2027-2032) & (K Units) Table 178. Middle East and Africa Aurora Kinase A Sales Market Share Forecast by Country (2027-2032) Table 179. Middle East and Africa Aurora Kinase A Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. Middle East and Africa Aurora Kinase A Market Size by Country (2021-2026) & (US$ Million) Table 181. Middle East and Africa Aurora Kinase A Market Share by Country (2021-2026) Table 182. Middle East and Africa Aurora Kinase A Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. Middle East and Africa Aurora Kinase A Market Share Forecast by Country (2027-2032) Table 184. Key Raw Materials Table 185. Raw Materials Key Suppliers Table 186. Aurora Kinase A Distributors List Table 187. Aurora Kinase A Customers List Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources Table 191. Primary Sources List of Figures Figure 1. Aurora Kinase A Image Figure 2. Global Aurora Kinase A Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Aurora Kinase A Market Size (2021-2032) & (US$ Million) Figure 4. Global Aurora Kinase A Sales (2021-2032) & (K Units) Figure 5. AMG-900 Image Figure 6. Global AMG-900 Sales YoY Growth (2021-2032) & (K Units) Figure 7. Ilorasertib Image Figure 8. Global Ilorasertib Sales YoY Growth (2021-2032) & (K Units) Figure 9. ENMD-2076 Image Figure 10. Global ENMD-2076 Sales YoY Growth (2021-2032) & (K Units) Figure 11. Danusertib Image Figure 12. Global Danusertib Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Aurora Kinase A Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Aurora Kinase A Market Share by Type 2025 VS 2032 Figure 17. North America Aurora Kinase A Sales Market Share in Volume by Type in 2025 Figure 18. North America Aurora Kinase A Sales Market Share in Value by Type in 2025 Figure 19. Europe Aurora Kinase A Sales Market Share in Volume by Type in 2025 Figure 20. Europe Aurora Kinase A Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Aurora Kinase A Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Aurora Kinase A Sales Market Share in Value by Type in 2025 Figure 23. Latin America Aurora Kinase A Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Aurora Kinase A Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Aurora Kinase A Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Aurora Kinase A Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Aurora Kinase A Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Brain Tumor Image Figure 30. Global Brain Tumor Sales YoY Growth (2021-2032) & (K Units) Figure 31. Ovarian Cancer Image Figure 32. Global Ovarian Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 33. Anaplastic Large Cell Lymphoma Image Figure 34. Global Anaplastic Large Cell Lymphoma Sales YoY Growth (2021-2032) & (K Units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global Aurora Kinase A Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Aurora Kinase A Market Share by Application 2025 VS 2032 Figure 39. North America Aurora Kinase A Sales Market Share in Volume by Application in 2025 Figure 40. North America Aurora Kinase A Sales Market Share in Value by Application in 2025 Figure 41. Europe Aurora Kinase A Sales Market Share in Volume by Application in 2025 Figure 42. Europe Aurora Kinase A Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Aurora Kinase A Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Aurora Kinase A Sales Market Share in Value by Application in 2025 Figure 45. Latin America Aurora Kinase A Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Aurora Kinase A Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Aurora Kinase A Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Aurora Kinase A Sales Market Share in Value by Application in 2025 Figure 49. North America Aurora Kinase A Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America Aurora Kinase A Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Aurora Kinase A Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Aurora Kinase A Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Aurora Kinase A Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe Aurora Kinase A Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Aurora Kinase A Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Aurora Kinase A Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Aurora Kinase A Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific Aurora Kinase A Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Aurora Kinase A Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Aurora Kinase A Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Aurora Kinase A Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America Aurora Kinase A Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Aurora Kinase A Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Aurora Kinase A Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Aurora Kinase A Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa Aurora Kinase A Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Aurora Kinase A Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Aurora Kinase A Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Aurora Kinase A Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Aurora Kinase A Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • AMG-900
  • Ilorasertib
  • ENMD-2076
  • Danusertib
  • Others
Applications
  • Brain Tumor
  • Ovarian Cancer
  • Anaplastic Large Cell Lymphoma
  • Others
Companies covered
  • Sanofi
  • Merck & Co., Inc.
  • Amgen Inc.
  • AbbVie Inc.
  • Vichem Chemie Research Ltd.
  • Vertex Pharmaceuticals Incorporated
  • Taiho Pharmaceutical Co., Ltd.
  • Sigma-Tau S.p.A.
  • Sareum Holdings Plc
  • Millennium Pharmaceuticals, Inc.
  • CASI Pharmaceuticals Inc.
  • Astex Pharmaceuticals, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Aurora Kinase A Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Aurora Kinase A Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Aurora Kinase A Market by Type
  6. 1.3.1 AMG-900
  7. 1.3.2 Ilorasertib
  8. 1.3.3 ENMD-2076
  9. 1.3.4 Danusertib
  10. 1.3.5 Others
  11. 1.4 Global Aurora Kinase A Market Size by Type
  12. 1.4.1 Global Aurora Kinase A Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Aurora Kinase A Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Aurora Kinase A Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Aurora Kinase A Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Aurora Kinase A Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Aurora Kinase A Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Aurora Kinase A Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Aurora Kinase A Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Aurora Kinase A Industry Trends
  2. 2.2 Aurora Kinase A Industry Drivers
  3. 2.3 Aurora Kinase A Industry Opportunities and Challenges
  4. 2.4 Aurora Kinase A Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Aurora Kinase A Revenue (2021-2026)
  2. 3.2 Global Top Players by Aurora Kinase A Sales (2021-2026)
  3. 3.3 Global Top Players by Aurora Kinase A Price (2021-2026)
  4. 3.4 Global Aurora Kinase A Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Aurora Kinase A Major Company Production Sites & Headquarters
  6. 3.6 Global Aurora Kinase A Company, Product Type & Application
  7. 3.7 Global Aurora Kinase A Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Aurora Kinase A Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Aurora Kinase A Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Aurora Kinase A Tier 1, Tier 2, and Tier 3
4 Aurora Kinase A Regional Status and Outlook
  1. 4.1 Global Aurora Kinase A Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Aurora Kinase A Historic Market Size by Region
  3. 4.2.1 Global Aurora Kinase A Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Aurora Kinase A Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Aurora Kinase A Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Aurora Kinase A Forecasted Market Size by Region
  7. 4.3.1 Global Aurora Kinase A Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Aurora Kinase A Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Aurora Kinase A Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Aurora Kinase A by Application
  1. 5.1 Aurora Kinase A Market by Application
  2. 5.1.1 Brain Tumor
  3. 5.1.2 Ovarian Cancer
  4. 5.1.3 Anaplastic Large Cell Lymphoma
  5. 5.1.4 Others
  6. 5.2 Global Aurora Kinase A Market Size by Application
  7. 5.2.1 Global Aurora Kinase A Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Aurora Kinase A Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Aurora Kinase A Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Aurora Kinase A Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Aurora Kinase A Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Aurora Kinase A Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Aurora Kinase A Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Aurora Kinase A Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Aurora Kinase A Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Aurora Kinase A Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Merck & Co., Inc.
  8. 6.2.1 Merck & Co., Inc. Company Information
  9. 6.2.2 Merck & Co., Inc. Business Overview
  10. 6.2.3 Merck & Co., Inc. Aurora Kinase A Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck & Co., Inc. Aurora Kinase A Product Portfolio
  12. 6.2.5 Merck & Co., Inc. Recent Developments
  13. 6.3 Amgen Inc.
  14. 6.3.1 Amgen Inc. Company Information
  15. 6.3.2 Amgen Inc. Business Overview
  16. 6.3.3 Amgen Inc. Aurora Kinase A Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Amgen Inc. Aurora Kinase A Product Portfolio
  18. 6.3.5 Amgen Inc. Recent Developments
  19. 6.4 AbbVie Inc.
  20. 6.4.1 AbbVie Inc. Company Information
  21. 6.4.2 AbbVie Inc. Business Overview
  22. 6.4.3 AbbVie Inc. Aurora Kinase A Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AbbVie Inc. Aurora Kinase A Product Portfolio
  24. 6.4.5 AbbVie Inc. Recent Developments
  25. 6.5 Vichem Chemie Research Ltd.
  26. 6.5.1 Vichem Chemie Research Ltd. Company Information
  27. 6.5.2 Vichem Chemie Research Ltd. Business Overview
  28. 6.5.3 Vichem Chemie Research Ltd. Aurora Kinase A Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Vichem Chemie Research Ltd. Aurora Kinase A Product Portfolio
  30. 6.5.5 Vichem Chemie Research Ltd. Recent Developments
  31. 6.6 Vertex Pharmaceuticals Incorporated
  32. 6.6.1 Vertex Pharmaceuticals Incorporated Company Information
  33. 6.6.2 Vertex Pharmaceuticals Incorporated Business Overview
  34. 6.6.3 Vertex Pharmaceuticals Incorporated Aurora Kinase A Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Vertex Pharmaceuticals Incorporated Aurora Kinase A Product Portfolio
  36. 6.6.5 Vertex Pharmaceuticals Incorporated Recent Developments
  37. 6.7 Taiho Pharmaceutical Co., Ltd.
  38. 6.7.1 Taiho Pharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Taiho Pharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Product Portfolio
  42. 6.7.5 Taiho Pharmaceutical Co., Ltd. Recent Developments
  43. 6.8 Sigma-Tau S.p.A.
  44. 6.8.1 Sigma-Tau S.p.A. Company Information
  45. 6.8.2 Sigma-Tau S.p.A. Business Overview
  46. 6.8.3 Sigma-Tau S.p.A. Aurora Kinase A Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sigma-Tau S.p.A. Aurora Kinase A Product Portfolio
  48. 6.8.5 Sigma-Tau S.p.A. Recent Developments
  49. 6.9 Sareum Holdings Plc
  50. 6.9.1 Sareum Holdings Plc Company Information
  51. 6.9.2 Sareum Holdings Plc Business Overview
  52. 6.9.3 Sareum Holdings Plc Aurora Kinase A Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sareum Holdings Plc Aurora Kinase A Product Portfolio
  54. 6.9.5 Sareum Holdings Plc Recent Developments
  55. 6.10 Millennium Pharmaceuticals, Inc.
  56. 6.10.1 Millennium Pharmaceuticals, Inc. Company Information
  57. 6.10.2 Millennium Pharmaceuticals, Inc. Business Overview
  58. 6.10.3 Millennium Pharmaceuticals, Inc. Aurora Kinase A Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Millennium Pharmaceuticals, Inc. Aurora Kinase A Product Portfolio
  60. 6.10.5 Millennium Pharmaceuticals, Inc. Recent Developments
  61. 6.11 CASI Pharmaceuticals Inc.
  62. 6.11.1 CASI Pharmaceuticals Inc. Company Information
  63. 6.11.2 CASI Pharmaceuticals Inc. Business Overview
  64. 6.11.3 CASI Pharmaceuticals Inc. Aurora Kinase A Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 CASI Pharmaceuticals Inc. Aurora Kinase A Product Portfolio
  66. 6.11.5 CASI Pharmaceuticals Inc. Recent Developments
  67. 6.12 Astex Pharmaceuticals, Inc.
  68. 6.12.1 Astex Pharmaceuticals, Inc. Company Information
  69. 6.12.2 Astex Pharmaceuticals, Inc. Business Overview
  70. 6.12.3 Astex Pharmaceuticals, Inc. Aurora Kinase A Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Astex Pharmaceuticals, Inc. Aurora Kinase A Product Portfolio
  72. 6.12.5 Astex Pharmaceuticals, Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Aurora Kinase A Sales by Country
  2. 7.1.1 North America Aurora Kinase A Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Aurora Kinase A Sales by Country (2021-2026)
  4. 7.1.3 North America Aurora Kinase A Sales Forecast by Country (2027-2032)
  5. 7.2 North America Aurora Kinase A Market Size by Country
  6. 7.2.1 North America Aurora Kinase A Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Aurora Kinase A Market Size by Country (2021-2026)
  8. 7.2.3 North America Aurora Kinase A Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Aurora Kinase A Sales by Country
  2. 8.1.1 Europe Aurora Kinase A Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Aurora Kinase A Sales by Country (2021-2026)
  4. 8.1.3 Europe Aurora Kinase A Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Aurora Kinase A Market Size by Country
  6. 8.2.1 Europe Aurora Kinase A Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Aurora Kinase A Market Size by Country (2021-2026)
  8. 8.2.3 Europe Aurora Kinase A Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Aurora Kinase A Sales by Country
  2. 9.1.1 Asia-Pacific Aurora Kinase A Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Aurora Kinase A Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Aurora Kinase A Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Aurora Kinase A Market Size by Country
  6. 9.2.1 Asia-Pacific Aurora Kinase A Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Aurora Kinase A Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Aurora Kinase A Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Aurora Kinase A Sales by Country
  2. 10.1.1 South America Aurora Kinase A Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Aurora Kinase A Sales by Country (2021-2026)
  4. 10.1.3 South America Aurora Kinase A Sales Forecast by Country (2027-2032)
  5. 10.2 South America Aurora Kinase A Market Size by Country
  6. 10.2.1 South America Aurora Kinase A Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Aurora Kinase A Market Size by Country (2021-2026)
  8. 10.2.3 South America Aurora Kinase A Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Aurora Kinase A Sales by Country
  2. 11.1.1 Middle East and Africa Aurora Kinase A Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Aurora Kinase A Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Aurora Kinase A Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Aurora Kinase A Market Size by Country
  6. 11.2.1 Middle East and Africa Aurora Kinase A Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Aurora Kinase A Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Aurora Kinase A Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Aurora Kinase A Value Chain Analysis
  2. 12.1.1 Aurora Kinase A Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Aurora Kinase A Production Mode & Process
  7. 12.2 Aurora Kinase A Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Aurora Kinase A Distributors
  10. 12.2.3 Aurora Kinase A Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst